Klobuchar: Drug Pricing Ripe For Presidential Debate Because A Top Issue For Constituents

September 26, 2016 at 6:10 PM
As presidential nominees Hillary Clinton and Donald Trump were set to take the stage for their first debate, Sen. Amy Klobuchar (D-MN) told stakeholders at a Center for American Progress Action Fund briefing Monday (Sept. 26) she hoped drug pricing would be raised because it is the “number one thing” she has heard from a number of constituents. The center, in turn, released an issue brief that proposes a drug price negotiation process for Medicare and private payers that incorporates...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.